
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval.
A high-dose version of Novo Nordisks injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries to claw back market share with its … [+832 chars]

